Pay in 4 interest-free payments of $6.15 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
glp 1 gip tirzepatide AIMS Health Quantity:Double-Pack ($69) Lifestyle:Vegetarian Cologne Germany 2023-11-11 Wegovy
Cologne Germany 2023-11-11 Wegovy Self Injection Stock Photo 2387703191 | Shutterstock
FDA submission is likely coming in 2026/2027 if the remaining readouts hold up Some other noteworthy drugs in the pipeline: Tirzepatide: The base drug is already approved for diabetes and obesity, but Lilly keeps expanding its label Kisunla (donanemab) for Alzheimer's Eloralintide: amylin receptor agonist heading to phase 3, at ADA it showed 20% weight loss on the amylin pathway alone MORF-057: bit of a wild card, after the $3.2 billion acquisition of Morphic
Lifestyle:Vegetarian
Quantity:Double-Pack ($69)
10.1186/s40885-019-0132-x 65 OhY
US$ 21.48
US$ 28.85
US$ 25.50
US$ 28.96
US$ 24.28
